1. Identification of Site-Specific Stroke Biomarker Candidates by Laser Capture Microdissection and Labeled Reference Peptide.
- Author
-
Lian T, Qu D, Zhao X, Yu L, and Gao B
- Subjects
- Animals, Brain pathology, Infarction, Middle Cerebral Artery metabolism, Infarction, Middle Cerebral Artery pathology, Male, Rats, Rats, Sprague-Dawley, Reference Standards, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Stroke etiology, Stroke metabolism, Tissue Distribution, Biomarkers metabolism, Brain metabolism, Infarction, Middle Cerebral Artery complications, Laser Capture Microdissection methods, Peptide Fragments metabolism, Stroke diagnosis
- Abstract
The search to date for accurate protein biomarkers in acute ischemic stroke has taken into consideration the stage and/or the size of infarction, but has not accounted for the site of stroke. In the present study, multiple reaction monitoring using labeled reference peptide (LRP) following laser capture microdissection (LCM) is used to identify site-specific protein biomarker candidates. In middle cerebral artery occlusion (MCAO) rat models, both intact and infarcted brain tissue was collected by LCM, followed by on-film digestion and semi-quantification using triple-quadrupole mass spectrometry. Thirty-four unique peptides were detected for the verification of 12 proteins in both tissue homogenates and LCM-captured samples. Six insoluble proteins, including neurofilament light polypeptide (NEFL), alpha-internexin (INA), microtubule-associated protein 2 (MAP2), myelin basic protein (MBP), myelin proteolipid protein (PLP) and 2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNP), were found to be site-specific. Soluble proteins, such as neuron-specific enolase (NSE) and ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCHL1), and some insoluble proteins, including neurofilament heavy polypeptide (NEFH), glial fibrillary acidic protein (GFAP), microtubule-associated protein tau (MAPT) and tubulin β-3 chain (TUBB3), were found to be evenly distributed in the brain. Therefore, we conclude that some insoluble protein biomarkers for stroke are site-specific, and would make excellent candidates for the design and analysis of relevant clinical studies in the future.
- Published
- 2015
- Full Text
- View/download PDF